B+
Bull case
25%
Probability
Target price
$7.50
Analysis reference price unavailable
Analysis 2026-08-21 · RankAlpha Sentiment Codex
LENZ
LENZ TherapeuticsBNasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
Current thesis
Early VIZZ persistence, expanding access through telehealth, national advertising, and international partnerships could support a stronger commercial ramp than current price expectations imply.
Posture
Constructive
Lead driver
Sentiment
What changed
Sentiment remains the lead driver in the composite, 7D delta +22.4.
What can break
Early launch metrics may not translate into durable prescription growth or repeat purchasing.
Momentum
4
Value
58
Sentiment
74
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $5.25 · Bull $7.50 · Bear $2.75Analysis 2026-08-21; returns require an exact persisted reference.
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-08-17 • Vendor: Data Vendor v1
Scores
As of 2026-09-10 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-21 • Model: RankAlpha Sentiment Codex
Investment thesisAs of 2026-09-10
Investment thesis
As of 2026-09-10
Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-09-10. Definitions
Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $25.00
Why
Momentum4 · Δ7d -1.6
Value58 · Δ7d 0.0
Sentiment74 · Δ7d +22.4
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.
Confirming evidence
- • Sentiment remains the lead driver in the composite, 7D delta +22.4.
Contradictions & invalidation
- • Early launch metrics may not translate into durable prescription growth or repeat purchasing.
- • International submissions and approvals are uncertain and may not produce expected milestone or royalty value.
- • Product revenue growth remains modest, retail data is weak, and commercial spending may not convert awareness into durable prescriptions.
Catalyst clock
2026-08-11
Q2 commercialization read-through
Lead driver: Sentiment · See AI snapshot
Momentum
4
9% active weight
Current posture
7d trendSoftening
Δ7d
-1.6
Δ21d
-0.0
Value
58
28% active weight
Current posture
7d trendFlat
Δ7d
0.0
Δ21d
+0.8
Sentiment
74
62% active weight
Current posture
7d trendImproving
Δ7d
+22.4
Δ21d
-19.1
Why this grade
Composite grade B. Momentum 3.6 / Value 58.0 / Sentiment 74.2
Scenario snapshot
Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-21. Scenario method
Most likely
B
Base case
50%
Probability
Target price
$5.25
Analysis reference price unavailable
Analysis 2026-08-21 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$2.75
Analysis reference price unavailable
Analysis 2026-08-21 · RankAlpha Sentiment Codex
Fundamentals (TTM)As of 2026-08-17
Fundamentals (TTM)
As of 2026-08-17
Market Cap
$150.5M
Beta
0.58
Shares Out
31.42M
P/E (TTM) · Derived
-1.7
P/S (TTM)
29.47
P/FCF (TTM) · Derived
-1.30
Rev YoY
+9.7%
EPS YoY
+91.5%
Gross Margin
+90.1%
Op Margin
-631.7%
Net Debt
-$291.53M
Current Ratio
13.55
As of 2026-09-10 • Updated nightlySource: Internal modelMethods & Data